Ascend Wellness Gets Green Light From New York State To Invest $73M In MedMen's Subsidiary

Almost a year after announcing its plans to invest $73 million in MedMen Enterprises Inc.‘s MMEN MMNFF subsidiary in New York, the vertically integrated cannabis Ascend Wellness Holdings, Inc. AAWH AAWH received the final New York state approval.

The company announced Thursday that it has gotten the green light from the New York Cannabis Control Board (CCB) and the Office of Cannabis Management of the CCB to move forward with the transaction.

AWH Founder Abner Kurtin said earlier this year that “the proposed transaction will bring fresh capital and a new perspective to New York’s medical marijuana program and its patients.”

Deal Details

Under the investment agreement, MedMen NY agreed to undertake around $73 million of MedMen’s current secured debt, while Ascend Wellness will make a $35 million cash investment in MedMen’s subsidiary.

Ascend Wellness New York will issue a senior secured promissory note in favor of MedMen NY’s senior secured lender in the amount of $28 million, secured by Ascend Wellness.

Furthermore, the New York-based company will obtain a controlling interest in MedMen NY of some 86.7% equity and would also be given an option to buy the rest of the interest.

Pursuant to the original terms of the agreement, Ascend Wellness must invest an extra $10 million, which should also be used to repay MedMen NY’s senior secured lender once recreational cannabis sales start in its dispensaries, to compensate for the extra equity in MedMen’s subsidiary.

In August, Ascend raised some $210 million through a senior secured term loan with Seaport Global Securities LLC as lead manager to finance its investment in MedMen NY, Inc.

More recent news from Ascend Wellness:

AAWH Price Action

Ascend Wellness’ shares traded 5.72% higher at $6.47 per share at the time of writing on Thursday.

Photo: Courtesy of Precondo CA on Unsplash

Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...